Showing results (1731-1740 of 3,672) with videos related to

Sort By:
Pageof 368
Trauma Surgery & Acute Care Open|May 30, 2025
Is fixation of a single end of flail segment rib fractures enough?Anthony Perugini, James Iandoli, Nicholas Pelz, et al.
Journal of Neurology|March 20, 2013
Thymectomy: role in the treatment of myasthenia gravisJ Spillane, M Hayward, N P Hirsch, et al.
Rapid Communications in Mass Spectrometry : RCM|March 1, 1994
The use of low-energy collisionally activated dissociation negative-ion tandem mass spectrometry for the characterization of dog and human urinary metabolites of the drug BW 1370U87L C Taylor, R L Johnson, L St John-Williams, et al.
Cardiovascular and Interventional Radiology|March 30, 1999
Balloon occlusion versus wedged hepatic venography using carbon dioxide for portal vein opacification during TIPSF C Taylor, D C Smith, G E Watkins, et al.
Experimental and Clinical Psychopharmacology|April 1, 2000
Tobacco craving: intensity-related effects of imagery scripts in drug abusersR C Taylor, N A Harris, E G Singleton, et al.
The Analyst|March 29, 2000
Determination of residues of the plant growth regulator chlormequat in pears by ion-exchange high performance liquid chromatography-electrospray mass spectrometryJ R Startin, S J Hird, M D Sykes, et al.
The American Journal of Sports Medicine|April 2, 1999
Comparison of the Single Assessment Numeric Evaluation method and two shoulder rating scales. Outcomes measures after shoulder surgeryG N Williams, T J Gangel, R A Arciero, et al.
British Journal of Pharmacology|November 23, 2000
Rapid activation of basolateral potassium transport in human colon by oestradiolB McNamara, D C Winter, J Cuffe, et al.
Journal of the American Academy of Dermatology|October 26, 2002
Health disparities in arthritis and musculoskeletal and skin diseases-the dermatology session: National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, December 15-16, 2000Susan C Taylor, A Paul Kelly, Natalie E Dupree, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virusL W Frick, C U Lambe, L St John, et al.
Pageof 368